Moreover, the present study also confirmed that the expression level of Claudin-4 was associated with lymph node metastasis and tumors ≥5 cm, suggesting that higher Claudin-4 expression may be associated with a poor prognosis in breast cancer. The gene discussed is CLDN4; the disease is breast carcinoma.